Trial · NCT01196416
Adverse events49
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 49
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Alanine aminotransferase increased | Blood and lymphatic system disorders | Treatment (RO4929097, Cisplatin, Vinblastine, Temozolomide) | 4 | 14 | |
| other | Alkaline phosphatase increased | Metabolism and nutrition disorders | Treatment (RO4929097, Cisplatin, Vinblastine, Temozolomide) | 2 | 14 | |
| other | Anemia | Blood and lymphatic system disorders | Treatment (RO4929097, Cisplatin, Vinblastine, Temozolomide) | 11 | 14 | |
| other | Anorexia | General disorders | Treatment (RO4929097, Cisplatin, Vinblastine, Temozolomide) | 1 | 14 | |
| other | Aspartate aminotransferase increased | Blood and lymphatic system disorders | Treatment (RO4929097, Cisplatin, Vinblastine, Temozolomide) | 2 | 14 | |
| other | Blood bilirubin increased | Metabolism and nutrition disorders | Treatment (RO4929097, Cisplatin, Vinblastine, Temozolomide) | 2 | 14 | |
| other | CPK increased | Blood and lymphatic system disorders | Treatment (RO4929097, Cisplatin, Vinblastine, Temozolomide) | 1 | 14 | |
| other | Constipation | Gastrointestinal disorders | Treatment (RO4929097, Cisplatin, Vinblastine, Temozolomide) | 1 | 14 | |
| other | Creatinine increased | Metabolism and nutrition disorders | Treatment (RO4929097, Cisplatin, Vinblastine, Temozolomide) | 4 | 14 | |
| other | Diarrhea | Gastrointestinal disorders | Treatment (RO4929097, Cisplatin, Vinblastine, Temozolomide) | 1 | 14 | |
| other | Dyspnea | Respiratory, thoracic and mediastinal disorders | Treatment (RO4929097, Cisplatin, Vinblastine, Temozolomide) | 1 | 14 | |
| other | Fatigue | General disorders | Treatment (RO4929097, Cisplatin, Vinblastine, Temozolomide) | 4 | 14 | |
| other | Flank pain | General disorders | Treatment (RO4929097, Cisplatin, Vinblastine, Temozolomide) | 2 | 14 | |
| other | Hypercalcemia | Metabolism and nutrition disorders | Treatment (RO4929097, Cisplatin, Vinblastine, Temozolomide) | 1 | 14 | |
| other | Hyperglycemia | Metabolism and nutrition disorders | Treatment (RO4929097, Cisplatin, Vinblastine, Temozolomide) | 12 | 14 | |
| other | Hyperkalemia | Metabolism and nutrition disorders | Treatment (RO4929097, Cisplatin, Vinblastine, Temozolomide) | 4 | 14 | |
| other | Hypermagnesemia | Metabolism and nutrition disorders | Treatment (RO4929097, Cisplatin, Vinblastine, Temozolomide) | 1 | 14 | |
| other | Hypertension | Cardiac disorders | Treatment (RO4929097, Cisplatin, Vinblastine, Temozolomide) | 1 | 14 | |
| other | Hypoalbuminemia | Metabolism and nutrition disorders | Treatment (RO4929097, Cisplatin, Vinblastine, Temozolomide) | 9 | 14 | |
| other | Hypocalcemia | Metabolism and nutrition disorders | Treatment (RO4929097, Cisplatin, Vinblastine, Temozolomide) | 11 | 14 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01196416/events